Published in Int Immunopharmacol on April 18, 2010
Immunogenicity of peptides of measles virus origin and influence of adjuvants. Vaccine (2005) 0.81
Concentration and purification of rubella virus using monolithic chromatographic support. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.81
Entrapment of ovalbumin into liposomes--factors affecting entrapment efficiency, liposome size, and zeta potential. J Liposome Res (2008) 0.80
Entrapment of peptidoglycans and adamantyltripeptides into liposomes: an HPLC assay for determination of encapsulation efficiency. J Liposome Res (2003) 0.80
Influence of charge ratio of liposome/DNA complexes on their size after extrusion and transfection efficiency. Int J Nanomedicine (2012) 0.79
Robustness testing of live attenuated rubella vaccine potency assay using fractional factorial design of experiments. Vaccine (2010) 0.78
Studying disulfide bond rearrangement by MALDI-RTOF PSD and MALDI-TOF/RTOF high-energy CID (20 keV) experiments of peptides derived from ammodytoxins. J Mass Spectrom (2011) 0.78
Modified glycopeptides related to cell wall peptidoglycan: conformational studies by NMR and molecular modelling. Bioorg Med Chem (2003) 0.77
Identification of proteins interacting with ammodytoxins in Vipera ammodytes ammodytes venom by immuno-affinity chromatography. Anal Bioanal Chem (2013) 0.76
Spin-labelling study of interactions of ovalbumin with multilamellar liposomes and specific anti-ovalbumin antibodies. Int J Biol Macromol (2006) 0.76
Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer. Int Immunopharmacol (2008) 0.76
Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response. Vaccine (2009) 0.76
Adjuvant activity of peptidoglycan monomer and its metabolic products. Vaccine (2003) 0.75
A spin labelling study of immunomodulating peptidoglycan monomer and adamantyltripeptides entrapped into liposomes. Biochim Biophys Acta (2003) 0.75
Effect of liposomal formulations and immunostimulating peptidoglycan monomer (PGM) on the immune reaction to ovalbumin in mice. J Liposome Res (2006) 0.75
Reversed-phase high-performance liquid chromatographic method for the determination of peptidoglycan monomers and structurally related peptides and adamantyltripeptides. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.75
Chromatography, mass spectrometry, and molecular modeling studies on ammodytoxins. Anal Bioanal Chem (2012) 0.75
Ammodytagin, a heterodimeric metalloproteinase from Vipera ammodytes ammodytes venom with strong hemorrhagic activity. Toxicon (2011) 0.75
Generation of ammodytoxin-anti-cathepsin B immuno-conjugate as a model for delivery of secretory phospholipase A2 into cancer cells. Toxicon (2007) 0.75
Effectiveness of novel PGM-containing incomplete Seppic adjuvants in rabbits. Vaccine (2007) 0.75
Influence of adjuvant-active peptidoglycan monomer on specific T cell responses in mice. Vaccine (2002) 0.75
The role of antibodies specific for toxic sPLA2s and haemorrhagins in neutralizing potential of antisera raised against Vipera ammodytes ammodytes venom. Comp Biochem Physiol C Toxicol Pharmacol (2008) 0.75
VaH3, one of the principal hemorrhagins in Vipera ammodytes ammodytes venom, is a homodimeric P-IIIc metalloproteinase. Biochimie (2013) 0.75
In vivo and ex vivo EPR detection of spin-labelled ovalbumin in mice. Int J Biol Macromol (2010) 0.75
Determination of DNA entrapment into liposomes using short monolithic columns. J Chromatogr A (2006) 0.75
Purification and characterization of l,(l/d)-aminopeptidase from Guinea pig serum. Prep Biochem Biotechnol (2006) 0.75
Novel mannosyl derivatives of peptidoglycan monomer: Synthesis and biological evaluation of immunomodulatory properties. Bioorg Med Chem (2009) 0.75
The standard mouse assay of anti-venom quality does not measure antibodies neutralising the haemorrhagic activity of Vipera ammodytes venom. Toxicon (2012) 0.75
Comparison of mouse and rabbit model for the assessment of strong PGM-containing oil-based adjuvants. Vet Immunol Immunopathol (2007) 0.75